FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2248854699> ?p ?o ?g. }

• W2248854699 endingPage "418" @default.
• W2248854699 startingPage "412" @default.
• W2248854699 abstract "Visual decline is one of the most prominent features of age-related disability among older adults. In 2012, more than 20.6 million American adults reported vision loss (Blackwell, Lucas, & Clarke, 2012), and worldwide, according to the World Health Organization (2014), more than 285 million people are estimated to have visual impairment. Individuals with visual impairments are affected by significant psychosocial stressors, functional limitations, and increased mortality (Kempen, Ballemans, Ranchor, van Rens, & Zijlstra, 2012). Studies have shown that older individuals with visual impairments have diminished ability to perform activities of daily living (Knudtson, Klein, Klein, Cruickshanks, & Lee, 2005), and demonstrate poor health and increased disability (Crews, Chou, Zhang, Zack, & Saaddine, 2014). Furthermore, individuals with vision loss are often socially isolated (Alma et al., 2011), and have increased levels of psychological distress, anxiety, and depression (Kempen et al., 2012; Rovner, Zisselman, & Shmuely-Dulitzki, 1996). Although studies have shown a relationship between vision loss and depression, Rovner et al. (2014) demonstrated that the combination of mental health treatments and low vision interventions halved the incidence of depressive disorders relative to standard low vision interventions alone in individuals with macular degeneration. Furthermore, there is a correlation between visual impairment and increased mortality (Jacobs, Hammerman-Rozenberg, Maaravi, Cohen, & Stessman, 2005; Christ, Lee, Lam, Zheng, & Arheart, 2008; McCarty, Nanjan, & Taylor, 2001; Cacciatore et al., 2004). Compared to individuals with hearing deficits, individuals with vision loss have higher morbidity and are more likely to suffer from diabetes mellitus, heart disease, and hypertension (Crews & Campbell, 2004; Crews, Jones, & Kim, 2006). Notably, an association has been identified between visual impairment and an increased risk of hospitalization, which is likely secondary to the reduced functional ability associated with visual impairment and other comorbidity (Evans, Smeeth, & Fletcher, 2008). It is noteworthy that reading prescription labels and self-administering the correct drug and dosage at correct intervals requires a level of vision that most individuals with visual disabilities are incapable of, even with appropriate optical or auxiliary aids. Studies have suggested that medication mismanagement may be related to vision loss (American Foundation for the Blind, 2008; Murray, Darnell, Weinberger, & Martz, 1986; Smith & Bailey, 2014). The American Foundation for the Blind in 2008 reported that individuals with visual impairments lack access to critical medication use instructions. Common negative consequences of visual impairment include not taking medications at proper dosages or mistakenly taking expired or incorrect medications (American Foundation for the Blind, 2008; Smith & Bailey, 2014). As shown previously, difficulty with medication adherence can cause detrimental health consequences (McCann et al., 2012; Gellad, Grenard, & Marcum, 2011; Hughes, 2004). Prior studies have noted that individuals with visual impairments are more than twice as likely to need help managing their medication compared to individuals with typical vision (McCann et al., 2012). Therefore, it is important to minimize barriers that impair proper adherence to medication regimens. [FIGURE 1 OMITTED] One medication-use device that is widely employed within the Department of Veterans Affairs is ScripTalk, created by Envision America (2014), an audible prescription reader that uses radio-frequency identification and text-to-speech technology to speak the prescription label to the user (Figure 1). The ScripTalk computer software can be used by a pharmacy to encode a microchip located in the prescription label with pertinent information, including the medication's name, proper dosage, side effects, warnings, and pharmacy name and telephone number. …" @default.
• W2248854699 created "2016-06-24" @default.
• W2248854699 creator A5004656959 @default.
• W2248854699 creator A5026510878 @default.
• W2248854699 creator A5062339745 @default.
• W2248854699 creator A5071001036 @default.
• W2248854699 date "2015-09-01" @default.
• W2248854699 modified "2023-09-23" @default.
• W2248854699 title "Efficacy of ScripTalk Automated Prescription Label Reader and Veterans with Visual Impairments" @default.
• W2248854699 cites W1970390622 @default.
• W2248854699 cites W1995130964 @default.
• W2248854699 cites W2007181464 @default.
• W2248854699 cites W2042947367 @default.
• W2248854699 cites W2049966702 @default.
• W2248854699 cites W2064498624 @default.
• W2248854699 cites W2071406891 @default.
• W2248854699 cites W2072394348 @default.
• W2248854699 cites W2072439859 @default.
• W2248854699 cites W2092416341 @default.
• W2248854699 cites W2109701219 @default.
• W2248854699 cites W2112975008 @default.
• W2248854699 cites W2162105189 @default.
• W2248854699 cites W2164562392 @default.
• W2248854699 cites W2169194416 @default.
• W2248854699 cites W2345813952 @default.
• W2248854699 cites W2943440423 @default.
• W2248854699 cites W89035171 @default.
• W2248854699 doi "https://doi.org/10.1177/0145482x1510900511" @default.
• W2248854699 hasPublicationYear "2015" @default.
• W2248854699 type Work @default.
• W2248854699 sameAs 2248854699 @default.
• W2248854699 citedByCount "3" @default.
• W2248854699 countsByYear W22488546992019 @default.
• W2248854699 countsByYear W22488546992021 @default.
• W2248854699 countsByYear W22488546992023 @default.
• W2248854699 crossrefType "journal-article" @default.
• W2248854699 hasAuthorship W2248854699A5004656959 @default.
• W2248854699 hasAuthorship W2248854699A5026510878 @default.
• W2248854699 hasAuthorship W2248854699A5062339745 @default.
• W2248854699 hasAuthorship W2248854699A5071001036 @default.
• W2248854699 hasConcept C15744967 @default.
• W2248854699 hasConcept C159110408 @default.
• W2248854699 hasConcept C2426938 @default.
• W2248854699 hasConcept C71924100 @default.
• W2248854699 hasConcept C99508421 @default.
• W2248854699 hasConceptScore W2248854699C15744967 @default.
• W2248854699 hasConceptScore W2248854699C159110408 @default.
• W2248854699 hasConceptScore W2248854699C2426938 @default.
• W2248854699 hasConceptScore W2248854699C71924100 @default.
• W2248854699 hasConceptScore W2248854699C99508421 @default.
• W2248854699 hasIssue "5" @default.
• W2248854699 hasLocation W22488546991 @default.
• W2248854699 hasOpenAccess W2248854699 @default.
• W2248854699 hasPrimaryLocation W22488546991 @default.
• W2248854699 hasRelatedWork W1506200166 @default.
• W2248854699 hasRelatedWork W1995515455 @default.
• W2248854699 hasRelatedWork W2048182022 @default.
• W2248854699 hasRelatedWork W2080531066 @default.
• W2248854699 hasRelatedWork W2604872355 @default.
• W2248854699 hasRelatedWork W2748952813 @default.
• W2248854699 hasRelatedWork W2899084033 @default.
• W2248854699 hasRelatedWork W3031052312 @default.
• W2248854699 hasRelatedWork W3032375762 @default.
• W2248854699 hasRelatedWork W3108674512 @default.
• W2248854699 hasVolume "109" @default.
• W2248854699 isParatext "false" @default.
• W2248854699 isRetracted "false" @default.
• W2248854699 magId "2248854699" @default.
• W2248854699 workType "article" @default.